Nomura Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Nomura Holdings’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Buy	+79,900	New	+$1.51M	﹤0.01%	1240
2026 Q1	–	Sell	-40,800	Closed	-$878K	–	2093
2025 Q4	$878K	Sell	40,800 -131,700	-76%	-$2.78M	﹤0.01%	1375
2025 Q3	$3.32M	Buy	172,500 +129,200	+298%	+$2.3M	0.01%	939
2025 Q2	$740K	Buy	43,300 +8,900	+26%	+$380K	﹤0.01%	1062
2025 Q1	$2.2M	Buy	+34,400	New	+$3.62M	﹤0.01%	1025
2024 Q3	–	Sell	-15,000	Closed	-$2.37M	–	1960
2024 Q2	$2.37M	Buy	+15,000	New	+$1.93M	﹤0.01%	890
2018 Q1	–	Sell	-550,000	Closed	-$30.7M	–	1658
2017 Q4	$30.7M	Sell	550,000 -336,500	-38%	-$17.8M	0.05%	205
2017 Q3	$40.2M	Buy	+886,500	New	+$35.4M	0.08%	136

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nomura Holdings's SRPT Position: Q2 2026 in Review

Nomura Holdings opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 95,000 shares worth $1.71M. The stake represents ﹤0.01% of the portfolio and ranks #1175 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in SRPT as recently as Q3 2025.

Nomura Holdings first reported a position in SRPT in Q3 2014 and has held it in 23 quarters since. The position peaked at $24.9M in Q1 2019. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Nomura Holdings held 95,000 shares of Sarepta Therapeutics worth $1.71M as of Q2 2026.
Sarepta Therapeutics was a new Nomura Holdings position in Q2 2026.
Sarepta Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1175 holding.
Nomura Holdings first reported a position in Sarepta Therapeutics in Q3 2014 and has held it in 23 quarters since.
Nomura Holdings's Sarepta Therapeutics position peaked at $24.9M in Q1 2019.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.